Will Eden's guest appearances

Will Eden

Village Global's Venture Stories

Clearer Thinking with Spencer Greenberg

Andy Matuschak

Jason Crawford

Michael Nielsen

Julia Galef

Tyler Cowen

Samo Burja

Kyle Samani

Dan Zuller

Travis Kling

Keith Rabois

Cal Newport

Nir Eyal

Ramit Sethi

Peter Thiel

Charles Eisenstein

OwlTail

Sam Rosen

Read the full transcript here. How straightforwardly should we communicate our preferences to others? How many times does a person need to say "yes" relative to the number of times they say "no" so that a relationship can be maintained? Most people probably use a mix of asking and guessing; but under what conditions should each strategy be employed? What are the costs and benefits for the askers, guessers, and the people of whom the explicit or implicit request is being made? Since even the act of asking a question can be revealing, how can we know when to disclose certain pieces of information about our preferences? Does asking or guessing work better in small or large groups? Is it more polite to guess or ask? How does "tell" culture differ from ask and guess cultures? Does asking for consent (instead of guessing about whether or not the person consents) in sexual situations kill the mood?Will Eden was on the podcast back in episode 040. You can read more about him there!Sam Rosen was on the podcast back in episode 002. You can read more about him there! [Read more]

<a href="https://podcast.clearerthinking.org/episode/114/#transcript" rel="nofollow" target="_blank">Read the full transcript here.</a> How straightforwardly should we communicate our preferences to others? How many times does a person need to say "yes" relative to the number of times they say "no" so that a relationship can be maintained? Most people probably use a mix of asking and guessing; but under what conditions should each strategy be employed? What are the costs and benefits for the askers, guessers, and the people of whom the explicit or implicit request is being made? Since even the act of asking a question can be revealing, how can we know when to disclose certain pieces of information about our preferences? Does asking or guessing work better in small or large groups? Is it more polite to guess or ask? How does "tell" culture differ from ask and guess cultures? Does asking for consent (instead of guessing about whether or not the person consents) in sexual situations kill the mood?Will Eden was on the podcast back in <a href="https://podcast.clearerthinking.org/episode/040" rel="nofollow" target="_blank">episode 040</a>. You can read more about him there!Sam Rosen was on the podcast back in <a href="https://podcast.clearerthinking.org/episode/002" rel="nofollow" target="_blank">episode 002</a>. You can read more about him there! [<a href="https://podcast.clearerthinking.org/episode/114/will-eden-and-sam-rosen-guess-culture-vs-ask-culture" rel="nofollow" target="_blank">Read more</a>]

Guess culture vs. ask culture (with Will Eden and Sam Rosen)

What are the benefits of studying history? How do we find useful historical analyses? Can learning about history save us from repeating it? Is America decaying as a nation, empire, and/or leading world power? Generally speaking, what causes empires to fail? Is the aging and decay experienced by organic bodies analogous to the aging and decay experienced by an empire (or by any complex system, for that matter)? What are all the reasons organisms age, decay, and die? What are the most promising avenues of exploration in longevity research? What kind of stressors on our bodies are beneficial? How accurate is the efficient market hypothesis? What kinds of catalysts force a market to value assets at their "intrinsic" value? How rational are markets?William Eden is currently an entrepreneur-in-residence at biotech founder and investor Errik Anderson's family office, Ulysses Diversified. Previously, he worked with Peter Thiel for six years and jointly led the Life Science Investments group at Thiel Capital focused on early-stage breakthrough biomedical technologies. His previous roles include the Chief Analytics Officer of Azumio, a digital health startup, and economist at the Federal Reserve Bank of New York during the 2008 global financial crisis. His Twitter handle is @WilliamAEden, and he and his wife have additional essays and podcasts and more at their blog.NOTE: After the recording, Will contacted us with the following correction. There is a family lineage with a congenital growth hormone deficiency called Laron Syndrome that lives in villages in Ecuador, but he had incorrectly identified them as indigenous people. They actually migrated there from Spain, where other members of the family still live with the same genetic mutation. They suffer from fewer diseases of aging like cancer and diabetes, but their lifespan is indeed no longer than average due to vulnerability to accidents and injuries. This serves to demonstrate the tradeoff between longevity and robustness under free living conditions for these types of anti-aging interventions.[Read more]

What are the benefits of studying history? How do we find useful historical analyses? Can learning about history save us from repeating it? Is America decaying as a nation, empire, and/or leading world power? Generally speaking, what causes empires to fail? Is the aging and decay experienced by organic bodies analogous to the aging and decay experienced by an empire (or by any complex system, for that matter)? What are all the reasons organisms age, decay, and die? What are the most promising avenues of exploration in longevity research? What kind of stressors on our bodies are beneficial? How accurate is the efficient market hypothesis? What kinds of catalysts force a market to value assets at their "intrinsic" value? How rational are markets?William Eden is currently an entrepreneur-in-residence at biotech founder and investor Errik Anderson's family office, Ulysses Diversified. Previously, he worked with Peter Thiel for six years and jointly led the Life Science Investments group at Thiel Capital focused on early-stage breakthrough biomedical technologies. His previous roles include the Chief Analytics Officer of Azumio, a digital health startup, and economist at the Federal Reserve Bank of New York during the 2008 global financial crisis. His Twitter handle is <a href="https://twitter.com/WilliamAEden" rel="nofollow" target="_blank">@WilliamAEden</a>, and he and his wife have additional essays and podcasts and more at their <a href="http://becomingeden.com/start-here/" rel="nofollow" target="_blank">blog</a>.NOTE: After the recording, Will contacted us with the following correction. There is a family lineage with a congenital growth hormone deficiency called Laron Syndrome that lives in villages in Ecuador, but he had incorrectly identified them as indigenous people. They actually migrated there from Spain, where other members of the family still live with the same genetic mutation. They suffer from fewer diseases of aging like cancer and diabetes, but their lifespan is indeed no longer than average due to vulnerability to accidents and injuries. This serves to demonstrate the tradeoff between longevity and robustness under free living conditions for these types of anti-aging interventions.[<a href="https://podcast.clearerthinking.org/episode/040/will-eden-history-and-longevity" rel="nofollow" target="_blank">Read more</a>]

History and Longevity (with Will Eden)

Laura Deming

Joining Erik on this episode are Laura Deming (@laurademing), creator of Longevity Fund, and Will Eden (@williamaeden), entrepreneur in residence with Errik Anderson at Ulysses and formerly of Thiel Capital. They talk about:- The history of biotech and the big trends and companies in the space over the past several decades.- The breakdown of the different areas within biotech.- The new business model in biotech that’s been driven by VCs.- How the public market in biotech companies is impacting the private market- The history of the FDA and how it has evolved over time, including the fact that in the beginning, the FDA only looked at whether a drug was safe, not whether it was effective.- How they would change the regulatory environment if they could wave a magic wand.- Why Laura says that the most effective individuals in biotech have a determinate worldview.- How longevity has emerged over the past several years, and the future of work in the space.Thanks for listening — if you like what you hear, please review us on your favorite podcast platform. Check us out on the web at villageglobal.vc or get in touch with us on Twitter @villageglobal.Venture Stories is brought to you by Village Global and is hosted by co-founder and partner, Erik Torenberg. Grace Chen is our audio engineer and the show is produced by Brett Bolkowy.

Joining Erik on this episode are Laura Deming (@laurademing), creator of Longevity Fund, and Will Eden (@williamaeden), entrepreneur in residence with Errik Anderson at Ulysses and formerly of Thiel Capital. They talk about: - The history of biotech and the big trends and companies in the space over the past several decades. - The breakdown of the different areas within biotech. - The new business model in biotech that’s been driven by VCs. - How the public market in biotech companies is impacting the private market - The history of the FDA and how it has evolved over time, including the fact that in the beginning, the FDA only looked at whether a drug was safe, not whether it was effective. - How they would change the regulatory environment if they could wave a magic wand. - Why Laura says that the most effective individuals in biotech have a determinate worldview. - How longevity has emerged over the past several years, and the future of work in the space. Thanks for listening — if you like what you hear, please review us on your favorite podcast platform. Check us out on the web at <a href="http://villageglobal.vc" rel="nofollow" target="_blank">villageglobal.vc</a> or get in touch with us on Twitter @villageglobal. Venture Stories is brought to you by Village Global and is hosted by co-founder and partner, Erik Torenberg. Grace Chen is our audio engineer and the show is produced by Brett Bolkowy.

The Past, Present, and Future of Biotech and Longevity with Laura Deming and Will Eden